LaCascia Michael 4
4 · Foghorn Therapeutics Inc. · Filed Nov 18, 2020
Insider Transaction Report
Form 4
LaCascia Michael
Chief Legal Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-11-17+162,162→ 162,162 totalExercise: $17.00Exp: 2030-11-16→ Common Stock (162,162 underlying)
Footnotes (1)
- [F1]25% of the shares underlying the stock option shall vest on November 9, 2021, with the remainder vesting in 12 substantially equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer through such applicable vesting dates.